Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE

Trial N/A Completed Aug. 8, 2016

Validation of a Diagnostic Self-assessment Scale Non-motor Fluctuations at the Parkinson's Patient

Trial N/A Completed Aug. 8, 2016

Timing of Acute Palliative Care Consultation in Critically Ill Patients

Trial N/A Unknown Aug. 7, 2016

Study Assessing Tolerability and Safety and Exploring the Immunogenicity and Therapeutic Activity of AFFITOPE® PD01A in PD-GBA Patients

Trial Phase 1 Withdrawn Aug. 4, 2016

Prediction of Dementia in Parkinson's Disease by Measuring Cerebral Metabolism With PET Scan

Trial N/A Unknown Aug. 3, 2016

Diagnosis of Parkinson's Disease Using Diffusion Magnetic Resonance Imaging

Trial N/A Completed Aug. 3, 2016

Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth

Trial Phase 3 Completed Aug. 3, 2016

Thoracic Spinal Cord Stimulation as a Symptomatic Treatment for Advanced Parkinson's Disease

Trial Phase 1 Unknown Aug. 1, 2016

The Effect of a Motor-cognitive Rehabilitation on Attention in Parkinsonian Patients

Trial N/A Completed July 28, 2016

The Electrophysiological Investigation of Higher Level Neural Manifestations of Freezing of Gait in Parkinson's Disease Patient

Trial N/A Completed July 27, 2016

Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

Trial Phase 4 Completed July 17, 2016

Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

Trial Phase 2 Completed July 14, 2016

Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)

Trial Phase 3 Completed July 13, 2016

SAM-e for the Treatment of Depression in Patients With Parkinson's Disease

Trial Phase 2 Completed July 12, 2016

Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease

Trial N/A Unknown July 12, 2016

Telemedicine Program in Parkinson's Disease (TELEPARK)

Trial N/A Unknown July 10, 2016

Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease

Trial N/A Completed July 3, 2016

Evaluation of a Personalized Physical Activity Coaching Program in Parkinson's Disease

Trial N/A Unknown June 27, 2016

Cannabis and Parkinson's Disease Tremor: A Natural History Study

Trial N/A Completed June 26, 2016

Phase IIb Study of Intranasal Glutathione in Parkinson's Disease

Trial Phase 2 Completed June 23, 2016